Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Phio Pharmaceuticals Corp. (PHIOW)

0.2   0 (0%) 06-04 15:52
Open: 0.1601 Pre. Close: 0.2
High: 0.2327 Low: 0.1601
Volume: 41,611 Market Cap: 4M
Phio Pharmaceuticals Corp., a biotechnology company, focuses on discovering and developing immuno-oncology therapeutics to treat cancer in the United States. The company's lead product candidate is RXI-109, an sd-rxRNA that reduces the expression of connective tissue growth factor, a critical regulator of several biological pathways involved in fibrosis, including scar formation in the skin and eye. The company also develops Samcyprone, a topical formulation of the small molecule diphenylcyclopropenone for the clearance of common warts; and RXI-231, an sd-rxRNA compound targeting tyrosinase for use as a cosmetic ingredient that enhances the appearance of uneven skin tone and pigmentation. In addition, it develops RXI-109 that reduces the progression of retinal scarring. The company has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zentrum München. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phi

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.09 - 0.091 0.091 - 0.091
Low: 0.089 - 0.089 0.089 - 0.09
Close: 0.089 - 0.09 0.09 - 0.091

Technical analysis

as of: 2019-11-08 4:30:58 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 0.12     One year: 0.14
Support: Support1: 0.05    Support2: 0.01
Resistance: Resistance1: 0.10    Resistance2: 0.12
Pivot: 0.06
Moving Average: MA(5): 0.09     MA(20): 0.06
MA(100):     MA(250):
MACD: MACD(12,26): 0.02     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 87.34     %D(3): 88.47
RSI: RSI(14): 62.92
52-week: High: 0.10  Low: 0.01  Change(%): 200.0
Average Vol(K): 3-Month: -10000000000  10-Days: 306

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
PHIOW has closed below upper band by 25.3%. Bollinger Bands are 0% narrower than normal.

Headline News

Mon, 19 Nov 2018
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp. - PRNewswire

Mon, 19 Nov 2018
RXi Pharmaceuticals changes name to Phio Pharmaceuticals - Seeking Alpha

Wed, 20 May 2020
DHT Holdings - Consensus Indicates Potential 55.8% Upside - DirectorsTalk Interviews

Thu, 21 May 2020
Eli Lilly and Company - Consensus Indicates Potential -.4% Downside - DirectorsTalk Interviews

Fri, 01 May 2020
Aridis Pharmaceuticals Inc. - Consenus Indicates Potential 202.7% Upside - DirectorsTalk Interviews

Tue, 28 Apr 2020
Correvio Pharma Corp. - Consenus Indicates Potential 163.4% Upside - DirectorsTalk Interviews

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  NA
Industry:  NA
Shares Out. (M)
Shares Float (M) 25
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.445
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.390
Profit Margin
Operating Margin -9526.92
Return on Assets (ttm) -51.2
Return on Equity (ttm) -113.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.405
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M) -5

Stock Valuations

PE Ratio -0.20
PEG Ratio
Price to Book value 0.23
Price to Sales -10000000000.00
Price to Cash Flow

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.